Clinical Trial Update: Study of Gemcitabine and Abraxane for Pancreas Cancer [Phase 2]

View source ↗

Summary

Georgetown University–sponsored Phase 2 trial evaluating gemcitabine in combination with Abraxane for pancreatic cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)

Snippet

Sponsor: Georgetown University | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED